May 11, 2015
Longueuil, Quebec, Canada – MENODYS is initiating a first in human clinical proof of concept with its innovative Scar Appearance Minimizing Device in patients undergoing an abdominoplasty. MENODYS has selected the Montreal Health Innovations Coordinating Center (MHICC), a division of the Montreal Heart Institute and Q&T Research, Sherbrooke, Quebec to coordinate this clinical trial to test MENODYS’ technology in 15 patients. Dr. Michel Chagnon, MD, FRCP, general surgeon, will be the principal investigator for this study. The primary objective of the study is to evaluate the benefits of the MENODYS’ device in minimizing the appearance of a scar over a period of 8 weeks of treatment with the device.
For more information on MENODYS’s Scar Appearance Minimizing Device, please visit www.menodys.com
OUR PARTNER INSTITUTIONS